Daily drug-use patterns were linked to different overdose and infection risks

Daily polysubstance use associated with HIV, HCV, and non-fatal overdose among people who inject drugs: A latent class analysis using nationwide data.

Drug and alcohol dependence β€’ β€’ Moderately Relevant
πŸ€–

AI Summary

This nationwide observational study examined how daily substance-use patterns were associated with overdose and infections among people who inject drugs (PWID). Researchers analyzed survey data from 11,347 participants recruited in 23 U.S. cities, grouping them by reported daily use of eight substances, including cannabis. The analysis identified four patterns: Opioid-Only Injection (46.79%), Polydrug-Polyroute (4.07%), Cocaine Dominant Polyroute OSPU (35.96%), and Meth Dominant Polyroute OSPU (13.18%).

After adjustment for reported covariates, the Opioid-Only Injection group had a higher proportion of positive HIV tests than each polysubstance group, and higher lifetime HCV prevalence than two of those groups. Polysubstance groups had higher proportions of non-fatal overdose than the Opioid-Only Injection group; the Polydrug-Polyroute group had more overdose episodes than the other groups. Cannabis was included as a use indicator, but the abstract does not report cannabis-specific associations. Because this was an observational analysis, it cannot show that a substance-use pattern caused these outcomes; this is an abstract-based summary and does not establish the effect of cannabis use.

πŸ’‘ Key Findings

1
The analysis identified four daily substance-use patterns among people who inject drugs, with cannabis included among the substances measured.
High
90%
2
The Opioid-Only Injection group had a higher proportion of positive HIV tests than all polysubstance groups, after adjustment for covariates.
High
80%
3
Polysubstance groups had higher proportions of non-fatal overdose than the Opioid-Only Injection group; the Polydrug-Polyroute group had more overdose episodes than the other groups.
High
80%
4
The abstract reports no cannabis-specific outcome association, and the observational analysis cannot establish causation.
High
95%

πŸ“„ Original Abstract

BACKGROUND: This study examined how distinct patterns of polysubstance use are associated with non-fatal overdose, human immunodeficiency virus (HIV) infection, and lifetime hepatitis C virus (HCV) infection among persons who inject drugs (PWID). METHODS: PWID were recruited from 23 U.S. cities for the 2018 National HIV Behavioral Surveillance. Latent class analysis was conducted using eight daily substance use indicators, including cannabis, opioid injection, cocaine-crack injection, methamphetamine injection, opioid non-injection, cocaine-crack non-injection, methamphetamine non-injection, and benzodiazepine non-injection. Associations between latent classes and sociodemographic variables, behavioral risk factors and non-fatal overdose, HIV infection, and lifetime HCV were analyzed using the R3STEP and Vermunt's 3-Step procedure. RESULTS: In total, 11,347 PWID were included in the analysis. Four classes were determined: 1) Opioid-Only Injection (46.79%), 2) Polydrug-Polyroute (4.07%), 3) Cocaine Dominant Polyroute OSPU (35.96%), and 4) Meth Dominant Polyroute OSPU (13.18%). After adjusting for covariates (e.g., sociodemographic, psychological distress, sexual and physical violence, attending drug treatment in the past 12 months), the Opioid-Only Injection class had a higher proportion of PWID who tested positive for HIV than all polysubstance classes and higher lifetime HCV than the Polydrug-Polyroute and Cocaine Dominant Polyroute OSPU classes. The polysubstance use classes had higher proportions of non-fatal overdose than the Opioid-Only Injection class, and the Polydrug-Polyroute class had greater non-fatal overdose episodes than all other classes. DISCUSSION: This study identified four novel polysubstance-polyroute typologies and their unique relationships with non-fatal overdose, HIV, and HCV risk among a nationwide sample of PWID. Interventions to mitigate infectious disease and non-fatal overdose risk among PWID may benefit from tailoring responses based on the needs of specific drug use combinations that individuals use daily.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.